GVAX

GVAX Uses, Dosage, Side Effects, Food Interaction and all others data.

GVAX is a chimeric monoclonal antibody which is used as an immunosuppressive drug.

GVAX is a monoclonal antibody that is being studied in the treatment of follicular non-Hodgkin lymphoma. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. GVAX binds to the protein CD80, which is found on certain normal and cancerous white blood cells.

Table Of contents

• GVAX
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	GVAX
Generic	Galiximab
Galiximab Other Names	Anti-CD80 monoclonal antibody, Galiximab
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in lymphoma (non-hodgkin's), psoriasis and psoriatic disorders, bone metastases, multiple myeloma, prostate cancer, and rheumatoid arthritis.

How GVAX works

GVAX, an IgG(1) anti-CD80 antibody, binds to CD80, a costimulatory molecule involved in T-cell activation. Reduction in lesional, activated T cells induces improvement in psoriatic plaques.

Half Life

13 to 24 days

Innovators Monograph

You find simplified version here GVAX